Evidence map›Paper›PMID 26087998›Full record

Trial reportAmerican journal of hematology2015

Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trial.

John C Wood, Sara Pressel, Zora R Rogers, Isaac Odame, Janet L Kwiatkowski, Margaret T Lee, William C Owen, Alan R Cohen, Timothy St Pierre, Matthew M Heeney and 4 more

Open access · greenAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in American journal of hematology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 8 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 8 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Hydroxyurea (hydroxycarbamide) for sickle cell disease.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Hydroxyurea (hydroxycarbamide) for sickle cell disease.The Cochrane database of systematic reviews · 2017
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. How we manage iron overload in sickle cell patients.British journal of haematology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 3 countries.

John C WoodChildren's Hospital Los Angeles, Los Angeles, California.
Sara PresselThe University of Texas Health Science Center, Houston, Texas.
Zora R RogersUniversity of Texas Southwestern Medical Center, Dallas, Texas.
Isaac OdameDivision of Haematology/Oncology, University of Toronto, The Hospital for Sick Children, Toronto, Canada.
Janet L KwiatkowskiChildren's Hospital of Philadelphia, Philadelphia, Penninsylvania.
Margaret T LeeColumbia University, New York, New York.
William C OwenChildren's Hospital of the King's Daughters, Norfolk, Virginia.
Alan R CohenSchool of Physics, University of Western Australia, Crawley, Australia.
Timothy St PierreSchool of Physics, University of Western Australia, Crawley, Australia.
Matthew M HeeneyBoston Children's Hospital, Boston, Massachusetts.
William H SchultzCincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Barry R DavisThe University of Texas Health Science Center, Houston, Texas.
Russell E WareCincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
TWiTCH Investigators
Cincinnati Children's Hospital Medical Center · USThe University of Texas Health Science Center at Houston · USUniversity of Western Australia · AUBoston Children's Hospital · USChildren's Hospital of Los Angeles · USChildren's Hospital of Philadelphia · USChildren's Hospital of The King's Daughters · USColumbia University · USThe University of Texas Southwestern Medical Center · USUniversity of Toronto · CA

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
TCD With Transfusions Changing to HydroxyureaR01HL095647 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI WARE, RUSSELL E · 2009 to 2013
$18.5M
TCD with Transfusions Changing to Hydroxyurea - SDMCR01HL095511 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DAVIS, BARRY R · 2009 to 2014
$3.6M
NCATS NIH HHS UL1 TR001425NHLBI NIH HHS 5 R01 HL095511-05NHLBI NIH HHS R01 HL095511NHLBI NIH HHS R01 HL095647NHLBI NIH HHS R01HL095647-05
6 · The paper itself

Abstract

Noninvasive, quantitative, and accurate assessment of liver iron concentration (LIC) by MRI is useful for patients receiving transfusions, but R2 and R2* MRI techniques have not been systematically compared in sickle cell anemia (SCA). We report baseline LIC results from the TWiTCH trial, which compares hydroxyurea with blood transfusion treatment for primary stroke prophylaxis assessed by transcranial Doppler sonography in pediatric SCA patients. Liver R2 was collected and processed using a FDA-approved commercial process (FerriScan®), while liver R2* quality control and processing were performed by a Core Laboratory blinded to clinical site and patient data. Baseline LIC studies using both MRI techniques were available for 120 participants. LICR2* and LICR2 results were highly correlated (r(2)  = 0.93). A proportional bias of LIC(R2*)/LIC(R2), decreasing with average LIC, was observed. Systematic differences between LICR2* and LICR2 were also observed by MRI manufacturer. Importantly, LICR2* and LICR2 estimates had broad 95% limits of agreement with respect to each other. We recommend LICR2 and LICR2* not be used interchangeably in SCA patients to follow individual patient trends in iron burden.

Indexed as

Transfusion ReactionAdolescentAnemia, Sickle CellAntisickling AgentsBenzoatesBiological AssayChildChild, PreschoolDeferasiroxDeferoxamineFemaleHumansHydroxyureaIronIron Chelating AgentsIron OverloadAntisickling AgentsBenzoatesDeferasiroxDeferoxamineHydroxyureaIronIron Chelating AgentsTriazoles

Identifiers

PMID26087998
PMCPMC4546569
OpenAlexW2100083745

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.